461 related articles for article (PubMed ID: 27581518)
21. Erythropoietin protects pancreatic β-cell line NIT-1 cells against cytokine-induced apoptosis via phosphatidylinositol 3-kinase/Akt signaling.
Shuai H; Zhang J; Zhang J; Xie J; Zhang M; Yu Y; Zhang L
Endocr Res; 2011; 36(1):25-34. PubMed ID: 21226565
[TBL] [Abstract][Full Text] [Related]
22. [Proliferative signal transmission mediated by EpoR in leukemic cell lines].
Fan H; Kanji S; Zhai M
Zhonghua Xue Ye Xue Za Zhi; 2000 Jun; 21(6):294-7. PubMed ID: 11876995
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective effects of erythropoietin against sevoflurane-induced neuronal apoptosis in primary rat cortical neurons involving the EPOR-Erk1/2-Nrf2/Bach1 signal pathway.
Zhang DX; Zhang LM; Zhao XC; Sun W
Biomed Pharmacother; 2017 Mar; 87():332-341. PubMed ID: 28064106
[TBL] [Abstract][Full Text] [Related]
24. Lack of expression and function of erythropoietin receptors in the kidney.
Elliott S; Busse L; Swift S; McCaffery I; Rossi J; Kassner P; Begley CG
Nephrol Dial Transplant; 2012 Jul; 27(7):2733-45. PubMed ID: 22167585
[TBL] [Abstract][Full Text] [Related]
25. Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma.
Mohyeldin A; Lu H; Dalgard C; Lai SY; Cohen N; Acs G; Verma A
Neoplasia; 2005 May; 7(5):537-43. PubMed ID: 15967106
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin receptor spliced forms differentially expressed in blind subterranean mole rats.
Shams I; Nevo E; Avivi A
FASEB J; 2005 Oct; 19(12):1749-51. PubMed ID: 16081499
[TBL] [Abstract][Full Text] [Related]
27. Erythropoietin-responsive sites in normal and malignant human lung tissues.
Yasuda Y; Hara S; Hirohata T; Koike E; Yamasaki H; Okumoto K; Hoshiai H
Anat Sci Int; 2010 Dec; 85(4):204-13. PubMed ID: 20397063
[TBL] [Abstract][Full Text] [Related]
28. The erythropoietin receptor is not required for the development, function, and aging of rods and cells in the retinal periphery.
Caprara C; Britschgi C; Samardzija M; Grimm C
Mol Vis; 2014; 20():307-24. PubMed ID: 24644405
[TBL] [Abstract][Full Text] [Related]
29. The distinct erythropoietin functions that promote cell survival and proliferation are affected by aluminum exposure through mechanisms involving erythropoietin receptor.
Vittori D; Pregi N; Pérez G; Garbossa G; Nesse A
Biochim Biophys Acta; 2005 Mar; 1743(1-2):29-36. PubMed ID: 15777837
[TBL] [Abstract][Full Text] [Related]
30. Erythropoietin activates the phosphoinositide 3-kinase/Akt pathway in human melanoma cells.
Kumar SM; Yu H; Fong D; Acs G; Xu X
Melanoma Res; 2006 Aug; 16(4):275-83. PubMed ID: 16845323
[TBL] [Abstract][Full Text] [Related]
31. Endogenous erythropoietin from astrocyte protects the oligodendrocyte precursor cell against hypoxic and reoxygenation injury.
Kato S; Aoyama M; Kakita H; Hida H; Kato I; Ito T; Goto T; Hussein MH; Sawamoto K; Togari H; Asai K
J Neurosci Res; 2011 Oct; 89(10):1566-74. PubMed ID: 21833990
[TBL] [Abstract][Full Text] [Related]
32. RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells.
Paragh G; Kumar SM; Rakosy Z; Choi SC; Xu X; Acs G
Am J Pathol; 2009 Apr; 174(4):1504-14. PubMed ID: 19264915
[TBL] [Abstract][Full Text] [Related]
33. Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients.
Lamanuzzi A; Saltarella I; Ferrucci A; Ria R; Ruggieri S; Racanelli V; Rao L; Annese T; Nico B; Vacca A; Ribatti D
Oncotarget; 2016 Mar; 7(12):14510-21. PubMed ID: 26919105
[TBL] [Abstract][Full Text] [Related]
34. Evidence of receptor-mediated elimination of erythropoietin by analysis of erythropoietin receptor mRNA expression in bone marrow and erythropoietin clearance during anemia.
Nalbant D; Saleh M; Goldman FD; Widness JA; Veng-Pedersen P
J Pharmacol Exp Ther; 2010 May; 333(2):528-32. PubMed ID: 20103588
[TBL] [Abstract][Full Text] [Related]
35. Recombinant human erythropoietin stimulates melanoma tumor growth through activation of initiation factor eIF4E.
Julius A; Desai A; Yung RL
Oncotarget; 2017 May; 8(18):30317-30327. PubMed ID: 28415825
[TBL] [Abstract][Full Text] [Related]
36. The tumor promoting roles of erythropoietin/erythropoietin receptor signaling pathway in gastric cancer.
Hu W; Zhang Y; Jiang Z; Wang L; Li J; Chen S; Dai N; Si J
Tumour Biol; 2016 Aug; 37(8):11523-33. PubMed ID: 27086036
[TBL] [Abstract][Full Text] [Related]
37. Skin regeneration with conical and hair follicle structure of deep second-degree scalding injuries via combined expression of the EPO receptor and beta common receptor by local subcutaneous injection of nanosized rhEPO.
Bader A; Ebert S; Giri S; Kremer M; Liu S; Nerlich A; Günter CI; Smith DU; Machens HG
Int J Nanomedicine; 2012; 7():1227-37. PubMed ID: 22419870
[TBL] [Abstract][Full Text] [Related]
38. The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells From clinic to bench - a critical review.
Szenajch J; Wcislo G; Jeong JY; Szczylik C; Feldman L
Biochim Biophys Acta; 2010 Aug; 1806(1):82-95. PubMed ID: 20406667
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma.
Acs G; Zhang PJ; Rebbeck TR; Acs P; Verma A
Cancer; 2002 Sep; 95(5):969-81. PubMed ID: 12209679
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
Arcasoy MO; Karayal AF
Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
